ACI
Archean Chemical Industries share price & financials
- Price
- ₹527.75
- Market cap
- ₹6.0k Cr
- Sector
- Chemicals
- Calls analysed
- 7
Archean Chemical Industries Limited Q1 FY27
What went well
- Standalone revenue of INR 3,321 million, up 14% YoY and 9% sequentially, marking the highest quarterly revenue in five quarters.
- Standalone EBITDA of INR 838.7 million, up 26.3% sequentially, with margins expanding from 21.8% in Q4 FY26 to 25.3%.
- Bromine volumes reached their highest in five quarters (4,175 tons), and realizations improved by 50% YoY, firm near INR 300 per kg.
What to watch
- Higher logistics costs and purchase price variance on raw materials negatively impacted year-on-year margins.
- Industrial salt volumes declined by 12% YoY to 982,000 tons, affected by vessel shortages, fuel supply issues, and order deferments due to the Middle East conflict.
What Archean Chemical Industries Limited does
Archean Chemical Industries processes natural sea brine at integrated coastal sites in Gujarat and Andhra Pradesh into industrial salt, bromine and sulphate of potash (SOP), selling to chlor-alkali, agrochemical, pharmaceutical, oil-drilling and water-treatment customers in India and overseas. Its subsidiary Acume Chemicals converts bromine into higher-value derivatives (PTA catalyst, clear brine fluids, flame retardants) at a Jhagadia plant, while Idealis Mudchemie (formerly Oren Hydrocarbon) makes drilling fluids and mud chemicals. The group is also building India's first integrated Silicon Carbide compound-semiconductor fab and ATMP packaging unit near Bhubaneswar (Odisha) through subsidiary SiCSem, alongside minority stakes in UK-based Clas-SiC Wafer Fab (SiC devices) and US-based Offgrid Energy Labs (zinc-bromide battery storage).
Segments
- Industrial Salt
- Bromine
- Sulphate of Potash (SOP)
- Bromine Derivatives
- Specialty Mud Chemicals
- Manufacturing plants
- 6 (Hajipir, Jhagadia, Mandvi, Nagari, Kodur & Info Valley-Bhubaneswar) across Gujarat, Andhra Pradesh & Odisha
- Industrial Salt production capacity
- 7.5 million MT per annum
- Bromine production capacity
- 42,000 MTPA (28,500 MTPA merchant + 14,000 MTPA captive)
- Sulphate of Potash (SOP) capacity
- 1,30,000 MTPA
- Silicon Carbide semiconductor fab capacity (under development)
- 60,000 wafers/year plus 96 million packaged units/year at the Bhubaneswar (Odisha) facility
- Bromine derivatives capacity (Acume Chemicals, Jhagadia)
- PTA catalyst 5,000 MTPA and Clear Brine Fluids 13,000 MTPA commissioned; Flame Retardant Bromine 10,000 MTPA under evaluation
Guidance record · Q1 FY27
what the last two calls moved 16 tracked 0 delivered 6 missed 10 open- Elemental Bromine Production Volume revised down said Q4 FY26 Promised: Close to 25,000 tons in FY27 Q1 FY27: Guidance changed from a full-year volume of 'close to 25,000 tons' to an exit run-rate of 20,000-25,000 tons by year-end. This represents a dilution of the original target.
- Idealis Mudchemie Plant Operations on track said Q4 FY26 Promised: 2 out of 3 plants operational at reasonable volume in H2 FY27 Q1 FY27: On track. Management expects meaningful volumes from pack/starch in H2 FY27, followed by bentonite/barite by year-end. Q1 revenue was minimal (INR 3.5 million) as expected.
All 16 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 12.0%, net profit down 25.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 240 | 242 | 346 | 292 | 233 −3% | 255 +5% | 301 −13% | 327 +12% |
| EBITDA | 75 | 80 | 88 | 78 | 63 −16% | 54 −32% | 44 −50% | 67 −14% |
| Net profit | 16 | 48 | 54 | 40 | 29 +81% | 24 −50% | 12 −78% | 30 −25% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −32.4% 1Y
1Y: ₹696.15 on 10 Sept 2025 → ₹470.45. High ₹715.6 (17 Sept 2025), low ₹470.45 (11 Sept 2026).
How the price took the results
close before → close after
- Q1 FY27
- +1.9%
- 3 Aug
- Q4 FY26
- −6.3%
- 13 May
- Q3 FY26
- −2.7%
- 6 Feb
- Q2 FY26
- −1.7%
- 18 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue fell 9.1% a year over 3 years, FY23 to FY26. Operating margin narrowed to 22.1%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹1.4k Cr | ₹1.3k Cr | ₹1.0k Cr | ₹1.1k Cr |
| Operating profit | ₹634 Cr | ₹462 Cr | ₹314 Cr | ₹239 Cr |
| Operating margin | 44.0% | 34.7% | 30.2% | 22.1% |
| Interest | ₹96 Cr | ₹9 Cr | ₹8 Cr | ₹25 Cr |
| Depreciation | ₹69 Cr | ₹72 Cr | ₹79 Cr | ₹94 Cr |
| Net profit | ₹383 Cr | ₹320 Cr | ₹163 Cr | ₹105 Cr |
| Net margin | 26.6% | 24.1% | 15.7% | 9.7% |
| Cash from operations | ₹496 Cr | ₹379 Cr | ₹176 Cr | ₹140 Cr |
| Free cash flow | ₹397 Cr | ₹249 Cr | ₹-81 Cr | ₹-242 Cr |
| ROCE | 45.0% | 25.0% | 13.0% | 7.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY20 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | — | ₹19 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr |
| Reserves | — | ₹243 Cr | ₹1.4k Cr | ₹1.7k Cr | ₹1.9k Cr | ₹1.9k Cr |
| Borrowings | — | ₹897 Cr | ₹69 Cr | ₹98 Cr | ₹281 Cr | ₹466 Cr |
| Other liabilities | — | ₹372 Cr | ₹255 Cr | ₹255 Cr | ₹258 Cr | ₹264 Cr |
| Total liabilities | — | ₹1.5k Cr | ₹1.8k Cr | ₹2.1k Cr | ₹2.4k Cr | ₹2.7k Cr |
| Fixed assets | — | ₹1.1k Cr | ₹1.1k Cr | ₹1.2k Cr | ₹1.4k Cr | ₹1.4k Cr |
| Capital work in progress | — | ₹17 Cr | ₹36 Cr | ₹48 Cr | ₹64 Cr | ₹182 Cr |
| Investments | — | ₹11 Cr | ₹210 Cr | ₹350 Cr | ₹377 Cr | ₹257 Cr |
| Other assets | — | ₹417 Cr | ₹399 Cr | ₹497 Cr | ₹572 Cr | ₹843 Cr |
| Total assets | — | ₹1.5k Cr | ₹1.8k Cr | ₹2.1k Cr | ₹2.4k Cr | ₹2.7k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public added +0.56 pp while DIIs trimmed −0.51 pp. The shareholder count shrank 11% to 67,113.
- Promoters
- 53.4%
- FIIs
- 11.0%
- DIIs
- 24.2%
- Public
- 11.4%
Since Jun 2025
- Public +0.56 pp
- DIIs −0.51 pp
- FIIs −0.05 pp
How it drifted, 12 quarters
Over this window FIIs went from 2.9% to 11.0% — +8.1 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 53.6%, FIIs 2.9%, DIIs 30.4%, Public 13.1%.Dec '23: Promoters 53.5%, FIIs 4.2%, DIIs 28.7%, Public 13.7%.Mar '24: Promoters 53.5%, FIIs 5.9%, DIIs 27.1%, Government 0.0%, Public 13.5%.Jun '24: Promoters 53.5%, FIIs 9.5%, DIIs 21.0%, Public 16.0%.Sep '24: Promoters 53.5%, FIIs 10.2%, DIIs 22.0%, Public 14.4%.Dec '24: Promoters 53.4%, FIIs 10.7%, DIIs 22.9%, Public 13.1%.Mar '25: Promoters 53.4%, FIIs 10.9%, DIIs 23.2%, Public 12.4%.Jun '25: Promoters 53.4%, FIIs 11.1%, DIIs 24.7%, Public 10.8%.Sep '25: Promoters 53.4%, FIIs 11.2%, DIIs 25.5%, Public 9.9%.Dec '25: Promoters 53.4%, FIIs 11.1%, DIIs 25.3%, Public 10.2%.Mar '26: Promoters 53.4%, FIIs 11.1%, DIIs 25.8%, Public 9.7%.Jun '26: Promoters 53.4%, FIIs 11.0%, DIIs 24.2%, Public 11.4%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- HDFC Mutual Fund - HDFC Multi Cap Fund Mutual fund newly disclosed 3.00% held
- ICICI Prudential Multicap Fund Mutual fund newly disclosed 1.01% held
The same filing shows 2 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Archean Chemical Industries Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Chemikas Speciality LLP | 30.53% | unchanged |
| Pendurthi Ranjit | 22.90% | unchanged |
| SBI Small Cap Fund Mutual fund | 6.88% | unchanged |
| DSP Small Cap Fund Mutual fund | 3.06% | −1.66 pp |
| HDFC Mutual Fund - HDFC Multi Cap Fund Mutual fund | 3.00% | newly disclosed |
| Goldman Sachs Funds - Goldman Sachs India Equity P Global fund house | 2.46% | unchanged |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund Mutual fund | 1.11% | unchanged |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 Insurer | 1.06% | −0.39 pp |
| ICICI Lombard General Insurance Company Ltd Insurer | 1.06% | unchanged |
| ICICI Prudential Multicap Fund Mutual fund | 1.01% | newly disclosed |
| Pendurthi Ravi | 0.00% | unchanged |
| HDFC Mutual Fund - HDFC Manufacturing Fund Mutual fund | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Mutual funds in ACI
Filings to Aug 2026
0 new, 1 added, 1 trimmed, 0 sold out — net −17.04 L shares (−12.6%).
- Held by funds
- ₹591 Cr
- 6 schemes
- Biggest holder
- SBI Smallcap Fund
- ₹214 Cr · 0.5% of that fund
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| SBI Smallcap Fund SBI Mutual Fund | ₹214 Cr | held | Jan '23 |
| HDFC Manufacturing Fund HDFC Mutual Fund | ₹100 Cr | +4.39 L | Aug '24 |
| HDFC Multi Cap Fund HDFC Mutual Fund | ₹95 Cr | held | Dec '22 |
| SBI MultiCap Fund SBI Mutual Fund | ₹93 Cr | −21.43 L | Nov '22 |
| Nippon India Small Cap Fund Nippon India Mutual Fund | ₹67 Cr | held | Nov '22 |
| HDFC Large and Mid Cap Fund HDFC Mutual Fund | ₹23 Cr | held | Feb '25 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Aug 2026
1 added, 1 trimmed — net −17.04 L shares (−12.6%)
- Funds are sitting on
- -8%
- vs est. average cost
- Held by funds
- ₹591 Cr
- 6 schemes · ≈ 10% of the company
- Biggest holder
- SBI Smallcap Fund
- ₹214 Cr · 0.5% of that fund
- Longest holder
- SBI MultiCap Fund
- 3y 10m · since Nov '22
Shares held by these funds +17%
Aug '23 1.40 cr shares Jul '26
What the price assumes
- Growth the price implies
- 30.6% a year
- for 7 years, fading to 4%
- It has actually compounded at
- Not enough history
- The gap
- —
- between what it did and what it must do
All earnings calls (7)
Read the Q1 FY27 call →Learn to analyse Archean Chemical Industries Limited
Guides on how to read this kind of business and the numbers that matter.